Welcome to our dedicated page for Nanophase Tech news (Ticker: NANX), a resource for investors and traders seeking the latest updates and insights on Nanophase Tech stock.
Solésence, Inc. (OTCQB: NANX), formerly Nanophase Technologies Corporation, generates frequent news related to mineral-based skin health technologies, beauty science, and corporate developments. Company announcements describe Solésence as a leader in scientifically driven health care solutions across beauty and life science categories, with a focus on mineral-based sun and environmental protection and skin health.
News items for NANX often cover financial results, including quarterly and full-year earnings releases that discuss revenue trends, profitability, and operational highlights. These releases may describe record revenue periods, changes in product mix, and investments in operations, research and development, and team expansion to support growth. They also provide details on production capabilities, such as expanded batch-making capacity and added clean room space for filling and assembly of products.
Corporate strategy and branding are another recurring theme. The company has announced its rebranding from Nanophase Technologies Corporation to Solésence, Inc., highlighting the success of its beauty science platform and its commitment to innovation, self-expression, and inclusivity in skin health. News coverage also includes information about Solésence Beauty Science winning industry awards for mineral-based formulations and participating in events such as the Chicago Innovation Awards and related recognition activities.
Investors following NANX news will also find updates on capital markets activity, including the company’s announcement that it received approval to transfer its listing to the Nasdaq Capital Market, where it will trade under the ticker symbol SLSN. In addition, the company regularly announces conference calls and webcasts to discuss financial results and provide business updates. For those tracking Solésence, the NANX news feed offers a centralized view of financial performance, operational progress, branding milestones, and capital markets developments.
Nanophase Technologies Corporation (NANX) has filed an 8-K following BASF's complaint in New Jersey, alleging a breach of exclusivity regarding a supply agreement. Nanophase's subsidiary, Solésence, was implicated in selling zinc oxide-based products. In response, Nanophase filed a Complaint for Declaratory Judgment in Cook County. Despite this legal conflict, management asserts confidence in their position, emphasizing that Solésence's intellectual property remains secure and will not hinder ongoing operations or growth potential. They remain hopeful for a negotiated resolution.
Nanophase Technologies Corporation (OTCQB: NANX) reported record Q2 revenue of $11.2 million, a 58% increase from $7.1 million in 2021. The Solésence division contributed significantly, achieving $7.1 million in revenue, up 58% YOY, while Personal Care Ingredients surged 86% to $3.3 million. The company has launched over 40 new products this quarter and consolidated its warehousing for better efficiency. With a focus on operational improvements and maintaining growth, Nanophase emphasizes high market demand and product differentiation.
Summary not available.
Nanophase Technologies Corporation (OTCQB: NANX) will release its Second Quarter 2022 financial news after the market closes on August 17, 2022. An investor conference call is scheduled for August 18, 2022, at 10:00 a.m. CDT to discuss the financial results and provide a business update. The call will feature President & CEO Jess Jankowski and COO Kevin Cureton. As a leader in minerals-based health care solutions, Nanophase focuses on innovations that protect skin and aid in medical diagnostics.
Solésence Beauty Science announced the receipt of a patent in Korea for its innovative Kleair™ technology, enhancing the effectiveness of zinc oxide in mineral sunscreens. This patented formulation improves UV blocking performance and aesthetic appeal, making it suitable for diverse skin tones. The patent, granted to parent company Nanophase Technologies, covers the use of Kleair™ in various product types including creams, gels, and sprays. This innovation aims to enhance skin health and aligns with global health interests by providing superior protection against UV damage.
Nanophase Technologies Corporation (OTCQB: NANX) reported a record $8.2 million in Q1 2022 revenue, a 15% increase from $7.1 million in Q1 2021. Key highlights include a 29% YOY rise in Solésence revenue and a 70% increase in Active Pharmaceutical Ingredients sales. The company plans to exceed $40 million in revenue for 2022, supported by strong demand and 24 million in open orders. However, production constraints due to staffing issues pose challenges. The addition of 30 new team members aims to enhance operational capacity and support growth.
Nanophase Technologies Corporation (OTCQB: NANX) will release its First Quarter 2022 financial results on May 11, 2022, after market close. An investor conference call is scheduled for May 12, 2022, at 10:00 a.m. CDT, led by President & CEO Jess Jankowski and COO Kevin Cureton. The call can be accessed via dial-in or on the company's website. Nanophase specializes in minerals-based healthcare solutions, focusing on products that protect skin and aid in medical diagnostics.
Nanophase Technologies Corporation (NANX) reported a record 70% year-over-year revenue growth, totaling $29.5 million for 2021. Solésence revenue soared by 170%, while Active Pharmaceutical Ingredients (API) sales grew by 40%. Despite these gains, the company faced operational challenges, including labor shortages and supply chain issues, which affected Q4 profitability. The company is focused on expanding its infrastructure to handle increased demand, recently leasing a new 260,000 sq. ft. facility. Expectations for Q1 2022 revenue are above $7 million, with ongoing partnerships and product launches.
Nanophase Technologies Corporation (OTCQB: NANX) announced it will release its fourth quarter and full year 2021 financial results after market close on March 31, 2022. An investor conference call is scheduled for April 5, 2022, at 10:00 a.m. CDT, to discuss these results and provide further updates. The call will feature President & CEO Jess Jankowski and COO Kevin Cureton. Participants can join the call via U.S. dial-in at 877-312-8776 or international at 408-774-4007. Access to the call will also be available through their website.
Nanophase Technologies Corporation (OTCQB: NANX) has announced the appointment of Ed Sieracki as Vice President of Brand Partnerships and Jennifer Bayon as Vice President of Licensing and Retail Partnerships. These roles aim to enhance customer success and growth among brand and retail partners in response to the increasing demand for Solésence products. Sieracki brings extensive experience from Minerals Technologies Inc., while Bayon has a successful track record from Paris Presents Incorporated. The company has also expanded its team to bolster client service and ongoing GMP efforts.